Seeking Alpha

Monsanto (MON -0.4%) signs a deal with Alnylam Pharmaceuticals (ALNY +3.6%) to use the...

Monsanto (MON -0.4%) signs a deal with Alnylam Pharmaceuticals (ALNY +3.6%) to use the biopharma's gene-silencing technology to improve its biopesticides. MON gains exclusive rights to use ALNY's platform technology and intellectual property; ALNY will receive $29M in upfront payments plus milestone payments and research funding.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|